GO:0004148 dihydrolipoyl dehydrogenase (NADH) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004148 describes the molecular function dihydrolipoyl dehydrogenase (NADH) activity, which catalyzes the NAD+-dependent oxidation of a dihydrolipoyl-lysyl protein to a lipoyl-lysyl protein, producing NADH and H+.
• This activity is the E3 component of alpha-ketoacid dehydrogenase complexes, including pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and branched-chain alpha-ketoacid dehydrogenase, and also functions in the glycine cleavage system as the L-protein.
• The reaction is reversible and uses FAD as a tightly bound cofactor, with NAD+ as the electron acceptor; the enzyme can also exhibit diaphorase and tellurite reductase activities.
• Dihydrolipoyl dehydrogenase activity is essential for mitochondrial energy metabolism, and its dysfunction is linked to metabolic disorders, neurodegeneration, and cancer.
• In plants, mitochondrial dihydrolipoyl dehydrogenase activity shapes photosynthesis and photorespiration, highlighting its evolutionary conservation.
• Researchers study this activity using enzyme assays, knockout models, and CRISPR-based editing to dissect its role in disease and metabolism.
Description
Dihydrolipoyl dehydrogenase (NADH) activity, encoded by GO:0004148, is a fundamental molecular function that catalyzes the reoxidation of dihydrolipoamide to lipoamide using NAD+ as an electron acceptor. This reaction is central to the function of multienzyme complexes that decarboxylate alpha-ketoacids, such as the pyruvate dehydrogenase complex (PDC), alpha-ketoglutarate dehydrogenase complex (OGDC), and branched-chain alpha-ketoacid dehydrogenase complex (BCKDC), as well as the glycine cleavage system. The enzyme is often referred to as E3 or L-protein, and its activity is indispensable for cellular energy production and metabolic homeostasis. Researchers study GO:0004148 because its dysregulation has been implicated in a range of pathologies, from metabolic disorders to cancer and neurodegeneration. The reaction is reversible, and the enzyme can also catalyze diaphorase and tellurite reductase reactions, expanding its functional repertoire. Understanding the molecular details of this activity is crucial for developing therapeutic strategies targeting metabolic enzymes.
dihydrolipoyl dehydrogenase (NADH) activity At A Glance
| GO ID | GO:0004148 |
|---|---|
| GO term | dihydrolipoyl dehydrogenase (NADH) activity |
| Ontology | molecular_function |
| Synonym | dihydrolipoamide dehydrogenase activity; lipoamide dehydrogenase; E3 component of alpha-ketoacid dehydrogenase complexes; diaphorase activity; L-protein activity |
| Major function | Catalyzes the NAD+-dependent oxidation of dihydrolipoyl-lysyl proteins to lipoyl-lysyl proteins, essential in alpha-ketoacid dehydrogenase complexes and the glycine cleavage system. |
| Cofactor | FAD (flavin adenine dinucleotide) |
| Substrates | Dihydrolipoyl-lysyl protein, NAD+ |
| Products | Lipoyl-lysyl protein, NADH, H+ |
| Reversibility | Reversible |
What Is GO:0004148?
GO:0004148, dihydrolipoyl dehydrogenase (NADH) activity, is defined as the catalysis of the reaction: N(6)-[(R)-dihydrolipoyl]-L-lysyl-[protein] + NAD+ = N(6)-[(R)-lipoyl]-L-lysyl-[protein] + NADH + H+. In other words, it is the NAD+-dependent oxidation of a dihydrolipoyl group attached to a lysine residue on a protein, converting it to a lipoyl group while reducing NAD+ to NADH and releasing a proton. This activity is synonymous with dihydrolipoamide dehydrogenase, lipoamide dehydrogenase, and E3 component of alpha-ketoacid dehydrogenase complexes, among others.
Why Is dihydrolipoyl dehydrogenase (NADH) activity Important in Cell Biology?
Dihydrolipoyl dehydrogenase (NADH) activity is a cornerstone of cellular metabolism, as it is required for the function of several multienzyme complexes that generate energy and biosynthetic precursors. Its role in the pyruvate dehydrogenase complex links glycolysis to the citric acid cycle, while its function in the alpha-ketoglutarate dehydrogenase complex is critical for the citric acid cycle itself. Additionally, its participation in the glycine cleavage system is vital for one-carbon metabolism. Dysregulation of this activity has been associated with metabolic diseases, neurodegeneration, and cancer, making it a target of intense research interest.
• Essential for mitochondrial energy production via pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexes.
• Involved in the glycine cleavage system, contributing to one-carbon metabolism.
• Dysfunction linked to metabolic disorders such as lactic acidosis and neurological deficits.
• Plays a role in cancer metabolism and cuproptosis-induced cell death.
• Shapes photosynthesis and photorespiration in plants, indicating broad biological significance.
• Exhibits diaphorase and tellurite reductase activities, expanding its functional roles.
• Target for drug development in parasitic infections due to its essentiality in pathogens.
• Regulated by NADH/NAD+ ratio, linking its activity to cellular redox state.
• Subject of intense structural and mechanistic studies due to its complex flavin chemistry.
• Used as a model enzyme for understanding flavoprotein catalysis and electron transfer.
What Happens During dihydrolipoyl dehydrogenase (NADH) activity?
Substrate Binding and Flavin Reduction
In simple terms: The enzyme grabs its substrate and passes electrons to its FAD cofactor.
The catalytic cycle begins with the binding of the dihydrolipoyl-lysyl substrate to the enzyme's active site, where the reduced lipoamide moiety transfers electrons to the tightly bound FAD cofactor, reducing it to FADH2. This step is facilitated by the enzyme's unique active site architecture, which positions the substrate for efficient hydride transfer. The reduction of FAD is accompanied by conformational changes that prepare the enzyme for NAD+ binding.
NAD+ Binding and NADH Release
In simple terms: NAD+ enters, accepts electrons from FADH2, and leaves as NADH.
Following flavin reduction, NAD+ binds to the enzyme and accepts a hydride from FADH2, regenerating FAD and producing NADH. The release of NADH is the rate-limiting step in the overall reaction and is sensitive to the cellular NADH/NAD+ ratio. The enzyme's affinity for NAD+ and its turnover rate are modulated by the redox state, ensuring that the reaction proceeds efficiently under physiological conditions.
Product Formation and Enzyme Regeneration
In simple terms: The oxidized lipoamide is released, and the enzyme is ready for another round.
After NADH release, the oxidized lipoyl-lysyl product dissociates from the active site, allowing the enzyme to return to its initial state. The enzyme can then participate in subsequent catalytic cycles. This step is crucial for the continuous operation of the parent multienzyme complexes, as the lipoyl moiety must be reoxidized to accept new acyl groups.
Integration with Multienzyme Complexes
In simple terms: The enzyme works as part of a larger machine that processes pyruvate and other molecules.
In the pyruvate dehydrogenase complex, dihydrolipoyl dehydrogenase (E3) interacts with the dihydrolipoyl transacetylase (E2) component to reoxidize the dihydrolipoamide arm, which is essential for the complex's catalytic cycle. Similar interactions occur in the alpha-ketoglutarate dehydrogenase and branched-chain alpha-ketoacid dehydrogenase complexes. The E3 component is also a part of the glycine cleavage system, where it is known as the L-protein.
Key Genes Involved in GO:0004148 dihydrolipoyl dehydrogenase (NADH) activity
The following genes encode proteins that either possess dihydrolipoyl dehydrogenase (NADH) activity or are intimately associated with its function in multienzyme complexes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DLD | Encodes the E3 subunit of alpha-ketoacid dehydrogenase complexes and the L-protein of the glycine cleavage system | Mutations cause E3 deficiency, a rare metabolic disorder; target for cancer and metabolic studies |
| PDHA1 | Pyruvate dehydrogenase E1 alpha subunit | Defects cause pyruvate dehydrogenase deficiency; interacts with DLD |
| PDHB | Pyruvate dehydrogenase E1 beta subunit | Mutations lead to PDH deficiency; part of the PDC complex |
| DLST | Dihydrolipoamide succinyltransferase (E2) of OGDC | Essential for OGDC assembly and function; links to DLD activity |
| DBT | Dihydrolipoamide branched chain transacylase (E2) of BCKDC | Mutations cause maple syrup urine disease; requires DLD for activity |
| GCSH | Glycine cleavage system H protein | Carries lipoate; interacts with DLD (L-protein) in glycine cleavage |
| GLDC | Glycine decarboxylase (P-protein) | Defects cause non-ketotic hyperglycinemia; part of glycine cleavage system |
| AMT | Aminomethyltransferase (T-protein) | Part of glycine cleavage system; mutations cause glycine encephalopathy |
| LIAS | Lipoyl synthase | Required for lipoylation of E2 subunits; affects DLD substrate availability |
| LIPT1 | Lipoyltransferase 1 | Attaches lipoate to target proteins; mutations cause metabolic disorders |
| LIPT2 | Lipoyltransferase 2 | Involved in mitochondrial lipoylation; supports DLD function |
| PDHX | Pyruvate dehydrogenase complex component X | Binds E3; mutations cause PDH deficiency |
| PDK1 | Pyruvate dehydrogenase kinase 1 | Phosphorylates and inhibits PDH; regulates flux through PDC |
| PDP1 | Pyruvate dehydrogenase phosphatase 1 | Dephosphorylates and activates PDH; modulates PDC activity |
| SIRT3 | NAD+-dependent deacetylase | Regulates mitochondrial enzymes including DLD via deacetylation |
| SIRT4 | Mitochondrial sirtuin | Inhibits PDH and regulates metabolic flux; may affect DLD indirectly |
| MPC1 | Mitochondrial pyruvate carrier 1 | Imports pyruvate into mitochondria; affects PDC substrate supply |
| MPC2 | Mitochondrial pyruvate carrier 2 | Works with MPC1; influences pyruvate oxidation and DLD demand |
How Is dihydrolipoyl dehydrogenase (NADH) activity Regulated?
Dihydrolipoyl dehydrogenase (NADH) activity is regulated at multiple levels. The enzyme's activity is sensitive to the NADH/NAD+ ratio, with high NADH levels inhibiting the reaction. In the pyruvate dehydrogenase complex, the E3 component is regulated by the phosphorylation state of the complex, which is controlled by PDK and PDP enzymes. Additionally, SIRT3-mediated deacetylation can modulate the activity of mitochondrial enzymes, including DLD. In plants, mitochondrial dihydrolipoyl dehydrogenase activity is regulated in response to light and metabolic demand, shaping photosynthesis and photorespiration.
dihydrolipoyl dehydrogenase (NADH) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DLD | E3 deficiency, lactic acidosis, neurological impairment | Patient-derived fibroblasts, Dld knockout mouse |
| PDHA1 | Pyruvate dehydrogenase deficiency, Leigh syndrome | Induced pluripotent stem cells, Pdha1 knockout models |
| DLST | Alpha-ketoglutarate dehydrogenase deficiency | Dlst knockout cell lines, zebrafish models |
| DBT | Maple syrup urine disease | Dbt knockout mice, patient cells |
| GLDC | Non-ketotic hyperglycinemia | Gldc knockout mice, iPSC-derived neurons |
Dihydrolipoyl Dehydrogenase Deficiency and Metabolic Disorders
Mutations in the DLD gene, which encodes dihydrolipoyl dehydrogenase, cause E3 deficiency, a rare autosomal recessive disorder characterized by lactic acidosis, neurological impairment, and early death. This condition affects the pyruvate dehydrogenase complex, alpha-ketoglutarate dehydrogenase complex, and branched-chain alpha-ketoacid dehydrogenase complex, leading to severe metabolic imbalances. Research using patient-derived cells and animal models has elucidated the biochemical consequences of DLD mutations, highlighting the importance of this activity for normal metabolism.
Role in Cancer and Cuproptosis
Recent studies have linked dihydrolipoyl dehydrogenase activity to cuproptosis, a copper-induced cell death pathway. Activation of dihydrolipoyl dehydrogenase induces NADH-reductive stress, which contributes to cuproptosis in cancer cells. This finding suggests that targeting this activity could be a therapeutic strategy in cancers that are sensitive to copper-induced cell death. Additionally, the enzyme's role in metabolic reprogramming makes it a potential target for cancer therapy.
Neurodegeneration and Mitochondrial Dysfunction
Impaired dihydrolipoyl dehydrogenase activity has been observed in neurodegenerative conditions, where mitochondrial dysfunction is a common feature. The enzyme's involvement in energy metabolism and redox balance means that its dysfunction can exacerbate oxidative stress and neuronal damage. Studies in model organisms have shown that reduced activity leads to altered mitochondrial dynamics and increased susceptibility to stress.
From dihydrolipoyl dehydrogenase (NADH) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of DLD knockout on mitochondrial metabolism? | DLD knockout cell lines (e.g., HEK293, HeLa) generated via CRISPR |
| How do point mutations in DLD affect enzyme activity? | Knock-in cell lines expressing mutant DLD (e.g., DLD-G194C) |
| Can overexpression of DLD rescue metabolic defects? | DLD overexpression in patient-derived fibroblasts |
| What is the role of DLD in cuproptosis? | DLD knockout or overexpression in cancer cell lines treated with copper ionophores |
| How does DLD acetylation regulate its activity? | Knock-in of acetylation-deficient or mimetic DLD mutants |
| What are the interactors of DLD in the PDC? | Tagged knock-in of DLD (e.g., FLAG, HA) for immunoprecipitation |
How to Study the dihydrolipoyl dehydrogenase (NADH) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADH production assay | Enzyme activity by NADH absorbance at 340 nm | Kinetic characterization of wild-type and mutant DLD |
| CRISPR knockout | Loss-of-function phenotypes | Studying essentiality in cell lines and mice |
| Site-directed mutagenesis | Effect of specific amino acid changes | Mapping catalytic residues and disease mutations |
| X-ray crystallography | Three-dimensional structure | Understanding substrate binding and catalysis |
| NMR spectroscopy | Flavin adduct formation and dynamics | Mechanistic studies of electron transfer |
| Metabolomics | Changes in metabolite levels | Assessing metabolic reprogramming in disease models |
| Immunoprecipitation | Protein-protein interactions | Identifying complex components and regulators |
| RNA-seq | Transcriptional changes | Evaluating cellular responses to DLD perturbation |
Enzymatic Activity Assays
Dihydrolipoyl dehydrogenase activity is typically measured spectrophotometrically by monitoring the reduction of NAD+ to NADH at 340 nm, using dihydrolipoamide as a substrate. This assay is robust and can be adapted for high-throughput screening. It is essential for characterizing mutant enzymes and evaluating the effects of inhibitors.
Genetic Knockout and Knockdown Models
CRISPR-Cas9-mediated knockout of DLD or other genes in the pathway allows researchers to study the consequences of loss of function in cell lines and animal models. Knockdown using siRNA or shRNA provides a complementary approach for transient inhibition. These models have been used to demonstrate the essentiality of dihydrolipoyl dehydrogenase activity in metabolism.
Structural and Biophysical Studies
X-ray crystallography and NMR spectroscopy have been used to elucidate the structure and mechanism of dihydrolipoyl dehydrogenase, including the formation of flavin C-4a adducts and the role of NAD+ binding. These techniques provide atomic-level insights into catalysis and regulation.
Metabolic Flux Analysis
Isotope tracing and metabolomics can quantify the flux through pathways that depend on dihydrolipoyl dehydrogenase activity, such as the citric acid cycle and glycolysis. These methods are powerful for assessing the impact of genetic or pharmacological perturbations on cellular metabolism.
How CRISPR Can Be Used to Study GO:0004148 dihydrolipoyl dehydrogenase (NADH) activity
Knockout
CRISPR-Cas9 knockout of DLD or related genes is used to create isogenic cell lines that lack dihydrolipoyl dehydrogenase activity. These models are invaluable for studying the metabolic consequences of enzyme loss, including effects on mitochondrial respiration, redox balance, and cell viability. Knockout mice for Dld exhibit severe metabolic phenotypes, mimicking human E3 deficiency.
Point Mutation
Knock-in of specific point mutations (e.g., DLD-G194C, a common disease-causing mutation) allows researchers to study the biochemical and cellular effects of altered enzyme activity. These models can reveal how mutations affect catalytic efficiency, protein stability, and interactions with partner proteins.
Knock-in
Tagged knock-in of DLD (e.g., with FLAG or HA epitope) enables affinity purification and proteomic analysis of the enzyme and its interacting partners. This approach can identify novel regulators and substrates, providing insights into the enzyme's broader roles.
Overexpression
Overexpression of wild-type or mutant DLD in cell lines can be used to study gain-of-function effects, such as increased flux through dehydrogenase complexes or induction of reductive stress. This is particularly relevant for cancer studies where DLD activation contributes to cuproptosis.
How EDITGENE Supports dihydrolipoyl dehydrogenase (NADH) activity Research
Researchers studying dihydrolipoyl dehydrogenase (NADH) activity-related genes often need to determine whether a candidate gene is causally involved in metabolic pathways, disease progression, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to facilitate these investigations, from gene knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for dihydrolipoyl dehydrogenase (NADH) activity research.
Frequently Asked Questions About dihydrolipoyl dehydrogenase (NADH) activity
What is dihydrolipoyl dehydrogenase (NADH) activity?
It is the enzyme activity defined by GO:0004148 that catalyzes the NAD+-dependent oxidation of dihydrolipoyl-lysyl proteins to lipoyl-lysyl proteins, producing NADH and H+.
What genes are involved in dihydrolipoyl dehydrogenase (NADH) activity?
The primary gene is DLD, which encodes the E3 subunit of alpha-ketoacid dehydrogenase complexes and the L-protein of the glycine cleavage system. Other associated genes include PDHA1, PDHB, DLST, DBT, and GCSH.
What diseases are associated with dihydrolipoyl dehydrogenase deficiency?
Mutations in DLD cause E3 deficiency, characterized by lactic acidosis, neurological impairment, and early death. It has also been linked to cancer and cuproptosis.
How is dihydrolipoyl dehydrogenase activity measured?
It is typically measured spectrophotometrically by monitoring NADH production at 340 nm using dihydrolipoamide as a substrate.
What is the role of dihydrolipoyl dehydrogenase in the pyruvate dehydrogenase complex?
It reoxidizes the dihydrolipoamide arm of the E2 subunit, allowing the complex to continue catalyzing pyruvate decarboxylation.
Can dihydrolipoyl dehydrogenase activity be targeted for cancer therapy?
Yes, recent studies suggest that activation of this enzyme induces NADH-reductive stress and cuproptosis, making it a potential target in certain cancers.
What cofactors are required for dihydrolipoyl dehydrogenase activity?
The enzyme requires FAD as a tightly bound cofactor and NAD+ as an electron acceptor.
How is dihydrolipoyl dehydrogenase activity regulated?
It is regulated by the NADH/NAD+ ratio, phosphorylation of the parent complexes, and post-translational modifications such as acetylation.
What model systems are used to study dihydrolipoyl dehydrogenase activity?
Common models include CRISPR knockout cell lines, patient-derived fibroblasts, and animal models such as Dld knockout mice.
What is the difference between dihydrolipoyl dehydrogenase and dihydrolipoamide dehydrogenase?
They refer to the same enzyme activity; dihydrolipoamide dehydrogenase is a synonym for dihydrolipoyl dehydrogenase (NADH) activity.
Conclusion
Dihydrolipoyl dehydrogenase (NADH) activity (GO:0004148) is a critical molecular function that underpins cellular energy metabolism and biosynthetic pathways. Its role in multienzyme complexes and the glycine cleavage system makes it essential for normal physiology, and its dysfunction is associated with severe metabolic disorders and cancer. Continued research using advanced CRISPR models and biochemical assays will further elucidate its mechanisms and therapeutic potential.
References
- 1. Zhang SY et al.. 2026. NADH-Reductive Stress Induced by Dihydrolipoamide Dehydrogenase Activation Contributes to Cuproptosis.. Adv Sci (Weinh) 13(9):e20444 PMID: 41346305
- 3. Timm S et al.. 2015. Mitochondrial Dihydrolipoyl Dehydrogenase Activity Shapes Photosynthesis and Photorespiration of Arabidopsis thaliana.. Plant Cell 27(7):1968-84 PMID: 26116608
- 4. Castro ME et al.. 2008. The dihydrolipoamide dehydrogenase of Aeromonas caviae ST exhibits NADH-dependent tellurite reductase activity.. Biochem Biophys Res Commun 375(1):91-4 PMID: 18675788
- 5. Patel MS et al.. 1995. Dihydrolipoamide dehydrogenase: activity assays.. Methods Enzymol 252:186-95 PMID: 7476353
- 6. O'Donnell ME et al.. 1983. Proton nuclear magnetic resonance investigation of the mechanism of flavin C-4a adduct formation induced by oxidized nicotinamide adenine dinucleotide binding to monoalkylated pig heart lipoamide dehydrogenase.. Biochemistry 22(16):3792-6 PMID: 6688532
- 7. Harmych S et al.. 2002. Role of dihydrolipoyl dehydrogenase (E3) and a novel E3-binding protein in the NADH sensitivity of the pyruvate dehydrogenase complex from anaerobic mitochondria of the parasitic nematode, Ascaris suum.. Mol Biochem Parasitol 125(1-2):135-46 PMID: 12467981
- 8. Chakraborty S et al.. 2008. Characterization of a dihydrolipoyl dehydrogenase having diaphorase activity of Clostridium kluyveri.. Biosci Biotechnol Biochem 72(4):982-8 PMID: 18391450
